Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£0.5 Million DHT Boost for Humane Research

Published: Monday, October 29, 2012
Last Updated: Monday, October 29, 2012
Bookmark and Share
Call for applications for next wave of grant funding also announced.

The Dr Hadwen Trust (DHT) has announced grants totalling £577,687, funding innovative and humane research into Alzheimer’s disease, Parkinson’s disease, oesophageal cancer, brain tumours and toxicology.

The research projects will be undertaken at five universities in England and Scotland. Their collective aim is to further the understanding and treatment of life threatening diseases while simultaneously developing alternative methods to replace the use of animals in biomedical research.

The potential number of animals to be saved from invasive and painful procedures as a result of the success of these projects is immeasurable.

The new projects aim to:
• Improve understanding of the role of proteins in development and cell function that will lead to a better understanding and treatment of Alzheimer’s disease (Royal Holloway University)

• Develop the use of plant cells to emulate the development of Parkinson’s disease in human cells (Westminster University)

• Three dimensional cell model to allow the study of Barrett’s oesophagus and its progression to cancer (Dundee University)

• Generate human liver cells from pluripotent human stem cells to replace animals in toxicology (Edinburgh University)

• Utilize an effective 3D blood-brain barrier model to identify nanoparticle systems which may be effective drug carriers used to combat brain tumours and other neurological diseases (Portsmouth University)

Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “We are delighted to announce funding for a further five ground-breaking, new research projects which promise to deliver benefits to both humans and animals. Each of these projects promises to significantly increase our understanding of devastating diseases whilst replacing animals used in scientific research.”

To find out more about the DHT research grants, please visit: www.drhadwentrust.org/research-and-funding/current-portfolio.

2012 Call for Grant Applications
The DHT is also making its annual call for applications for the next wave of grants: www.drhadwentrust.org/research-and-funding/research-funding-overview.

Awarded in summer 2013, the deadline for preliminary applications is 17th December 2012.

Kailah Eglington, continues: “In making research grants available annually, we are urging all scientists to think about how they can help shape a more effective and humane future for medical research by using non-animal methods in their work.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!